May 27, 2025
Willkie advised Sagard on the sale of its majority stake in Sterimed Group, a leading provider of sterile medical packaging solutions, and its reinvestment in the company as part of a management-led consortium.
On May 22, Sterimed announced that it entered into an agreement to strengthen and reshuffle its capital base around its management team. Sagard, which, represented by Willkie, acquired a majority stake in Sterimed in 2019, invested in the company as part of consortium that includes the management team, IK Partners, and a club of new investors – Société Générale CP, Geneo CE, Capza and Investir pour l’Enfance – named “Friends of Sterimed.”
Sagard Mid Cap is a French investment fund that provides equity capital to support the development of mid-sized companies led by ambitious teams.
The Willkie team was led by partners Christophe Garaud and Hugo Nocerino with associate Lafia Chaïb, and included partner Faustine Viala and associates Maud Boukhris and Hana Rousse.
